The eVTOL Boom Is Starting Now: Here's What's Happening in 2026

The core thesis is that 2026 is the year eVTOL moves from concept validation into early commercialization. The speaker repeatedly says the industry has already cleared the “does the physics work?” debate and is now entering a “show me how it’s going to make money” phase. In that framing, the main upside is not full Jetsons-style consumer flying cars, but the first practical commercial uses: cargo, medical evacuation, emergency response, and limited passenger service in specific markets. Joby is presented as the leading name and a near-term beneficiary of sector momentum. The speaker says Joby is up about 20% on the week, has nearly completed certification, and received its first FAA-certified simulator, which should allow pilot training ahead of a Dubai launch later in the year. …

1. 2026 is framed as the eVTOL sector’s first real commercialization year, not the full consumer flying-car era.
2. Joby and Archer are seen as the leading U.S. names, with certification as the main gating item.
3. Vertical Aerospace is cast as a potentially overlooked competitor with a different airline-supply-chain model.
4. Beta is a cargo-first, well-capitalized newcomer that could get to market faster by avoiding passenger complexity.
5. EHang is the only name described as commercially live, but its international scalability is uncertain.
6. The speaker is constructive on the sector but repeatedly stresses that it remains high-risk and volatile.

• The speaker presents 2026 commercialization as broadly imminent, but the transcript offers little hard evidence beyond stated milestones and optimism.
• The comparison to Boeing/Airbus is suggestive rather than rigorous; these eVTOL firms are still pre-scale and not comparable on business durability yet.
• Vertical Aerospace is described as an overlooked dark horse, but the argument leans heavily on product size and business-model analogy rather than demonstrated execution.
• EHang is said to be commercially launched, yet the discussion concedes its path may have been unusually favorable in China, which weakens the cross-market implication.
• The idea that a billion-dollar raise materially secures Beta’s advantage is plausible, but the transcript does not quantify burn, timing, or execution risk.